Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lyell Immunopharma (LYEL) Interest & Investment Income (2020 - 2025)

Historic Interest & Investment Income for Lyell Immunopharma (LYEL) over the last 6 years, with Q3 2025 value amounting to $3.3 million.

  • Lyell Immunopharma's Interest & Investment Income fell 4524.73% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.3 million, marking a year-over-year decrease of 4158.28%. This contributed to the annual value of $24.1 million for FY2024, which is 262.23% up from last year.
  • As of Q3 2025, Lyell Immunopharma's Interest & Investment Income stood at $3.3 million, which was down 4524.73% from $3.3 million recorded in Q2 2025.
  • In the past 5 years, Lyell Immunopharma's Interest & Investment Income registered a high of $7.1 million during Q4 2023, and its lowest value of $218000.0 during Q2 2021.
  • Over the past 5 years, Lyell Immunopharma's median Interest & Investment Income value was $3.5 million (recorded in 2022), while the average stood at $3.5 million.
  • As far as peak fluctuations go, Lyell Immunopharma's Interest & Investment Income tumbled by 8841.04% in 2021, and later skyrocketed by 103274.56% in 2023.
  • Quarter analysis of 5 years shows Lyell Immunopharma's Interest & Investment Income stood at $323000.0 in 2021, then surged by 969.04% to $3.5 million in 2022, then soared by 105.15% to $7.1 million in 2023, then tumbled by 30.55% to $4.9 million in 2024, then plummeted by 33.62% to $3.3 million in 2025.
  • Its Interest & Investment Income stands at $3.3 million for Q3 2025, versus $3.3 million for Q2 2025 and $3.9 million for Q1 2025.